Discover how Laverdia CA1 (verdinexor) treats canine lymphoma. Learn about the mechanism of action, handling precautions, and ...

Zydus Lifesciences has received tentative approval from the United States Food and Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg (USRLD: Farxiga Tablets, 5 mg and 10 mg).

Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the ...

The Ozempic pill will be launched in Q2 2026 and be available in doses 1.5 mg, 4 mg, and 9 mg.

The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA ...

Zydus Lifesciences has received tentative approval from the U.S. Food and Drug Administration (U.S. FDA) for diabetes drug Dapagliflozin Tablets, 5 mg and 10 mg, a generic of AstraZeneca ...

The Subject Expert Committee (SEC), functional under the Central Drugs Standard Control Organisation (CDSCO), has granted ...

Ahmedabad, Feb. 4 -- Ahmedabad:Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as ...

Which liquid iron supplements are best? While most people get the iron they need from their diet, certain conditions or illnesses may increase your risk of a deficiency. This makes it necessary to use ...

Zydus receives US FDA tentative approval for dapagliflozin tablets, 5 mg and 10 mg: Our Bureau, Mumbai Wednesday, February 4, 2026, 17:05 Hrs [IST] Zydus Lifesciences Limited has ...

The company has filed a supplemental drug application for Ozempic tablets 25 mg for use in adults with type 2 diabetes. The U.S. Food and Drug Administration has already approved Ozempic (semaglutide) ...

Zydus Lifesciences on Wednesday has received approval from the US health regulator to market a generic diabetes drug in the US market. The company has ...